Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective
Table 1
Current active clinical trials investigating malignant bowel obstruction.
Trials identifier
Trial name
Design
Intervention
NCT03260647
Risk-stratified multidisciplinary ambulatory management of malignant bowel obstruction in gynecological cancers (MAMBO)
Prospective observational study
Multidisciplinary MBO care program
NCT02365584
Quality of life in Patients with inoperable malignant bowel obstruction (QOL in IMBO)
Phase II, multicentre, RCT
Lanreotide with standard care versus standard care alone
NCT02275338
Study to assess efficacy and safety of lanreotide autogel 120 mg in treatment of clinical symptoms associated with inoperable malignant intestinal obstruction (IMIO)
Phase II, multicenter open label study
Lanreotide
NCT02270450
S1316, surgery or nonsurgical management in treating patients with intra-abdominal cancer and bowel obstruction
